ATLANTA--(BUSINESS WIRE)--Inhibitex, Inc. (Nasdaq: INHX), a biopharmaceutical company focused on developing products to treat and prevent serious infectious diseases, announced today that Russell H. Plumb, president and chief executive officer of Inhibitex, Inc., is scheduled to present at the following two conferences in November 2008:
